Douglas Brodie, CFA

AAA

15 Years of experience

Focus on high-growth companies

Current firm: Baillie Gifford

Professional background

Joined Baillie Gifford in 2001.

Educational background

Dphil in Molecular Immunology, Oxford University. BSc in Molecular Biology & Biochemistry, Durham University.

Performance

11.25%

Manager Annualised Return Since Inception

6.55%

Benchmark Annualised Return since Inception

Manager Performance

Manager

Benchmark

Dif.

Inception*

11.25%

6.55%

4.7%

10Y

13.81%

11.54%

2.27%

5.73%

6.24%

-0.51%

*Inception date: 11/12/2007

Data as at 30 September 2022.

Risk Statement / Disclaimer: Data is collected by Tenvalue. Care has been taken to ensure that the information is accurate, but Tenvalue neither warrants nor guarantees the contents, nor does it accept any responsibility for errors, inaccuracies or omissions herein. Past performance does not necessarily indicate future returns and should not be the sole reason for making an investment decision. The value of investments and any income from them can fall as well as rise. This listing is for informational purposes only. You should not construe any of this material as investment, financial or other advice.

BG Global Discovery Fund

Value investing using fundamental analysis

Benchmark
MSCI World Small, net / FTSE UK SMALL EX IT TOTAL

Class
Class B

ISIN
GB0006059330

AUM
1,019,518,765.41 €

Ongoing Charges
0.78%